Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy

Greenlee, 2001, Cancer statistics, CA Cancer J Clin, 51, 15, 10.3322/canjclin.51.1.15 Duska, 1999, Epithelial ovarian carcinoma in the reproductive age group, Cancer, 85, 2623, 10.1002/(SICI)1097-0142(19990615)85:12<2623::AID-CNCR19>3.0.CO;2-O Plaxe, 1993, Profiles of women age 30–39 and age less than 30 with epithelial ovarian cancer, Obstet Gynecol, 81, 651 Rodriguez, 1994, National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age, Cancer, 73, 1245, 10.1002/1097-0142(19940215)73:4<1245::AID-CNCR2820730419>3.0.CO;2-5 Swerenton, 1985, Ovarian carcinoma: a multivariate analysis of prognostic factors, Obstet Gynecol, 65, 264 Smedley, 1985, Age as a prognostic factor in epithelial ovarian carcinoma, Br J Obstet Gynaecol, 92, 839, 10.1111/j.1471-0528.1985.tb03056.x Scully, 1970, Recent progress in ovarian cancer, Hum Pathol, 1, 73, 10.1016/S0046-8177(70)80005-3 DiSaia, 1990, Fertility-sparing treatment of patients with ovarian cancer, Comprehens Ther, 16, 35 Julian, 1971, The biologic behavior of low-grade papillary serous carcinoma of the ovary, Obstet Gynecol, 40, 860 Bostwick, 1986, Ovarian epithelial tumors of borderline malignancy, Cancer, 58, 2052, 10.1002/1097-0142(19861101)58:9<2052::AID-CNCR2820580916>3.0.CO;2-5 Gallion, 1988, Ovarian dysgerminoma. Report of seven cases and review of the literature, Am J Obstet Gynecol, 158, 591, 10.1016/0002-9378(88)90036-1 Lim-Tam, 1988, Ovarian cystectomy for serous borderline tumors. A follow-up study of 35 cases, Obstet Gynecol, 72, 775 Casey, 1993, Epithelial ovarian tumors of borderline malignancy: long-term follow-up, Gynecol Oncol, 50, 316, 10.1006/gyno.1993.1218 Casey, 1996, Dysgerminoma: the role of conservative surgery, Gynecol Oncol, 63, 352, 10.1006/gyno.1996.0335 Stier, 1996, Laparotomy to complete staging of presumed early ovarian cancer, Obstet Gynecol, 87, 737, 10.1016/0029-7844(96)00021-X Brewer, 1999, Outcome and reproductive function after chemotherapy for ovarian dysgerminoma, J Clin Oncol, 17, 2670, 10.1200/JCO.1999.17.9.2670 McHale, 1999, Fertility-sparing treatment of patients with ovarian cancer, Comprehens Ther, 25, 144, 10.1007/BF02889610 Low, 2000, Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors, Cancer, 89, 391, 10.1002/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V Morice, 2001, Clinical outcomes and fertility results after conservative treatment for ovarian borderline tumor, Fertil Steril, 75, 92, 10.1016/S0015-0282(00)01633-2 Miyazaki, 1988, Preservation of ovarian function and reproductive ability in patients with malignant ovarian tumors, Gynecol Oncol, 30, 329, 10.1016/0090-8258(88)90247-8 Raspagliesi, 1997, Conservative surgery in high-risk epithelial ovarian carcinoma, J Am Col Surg, 185, 457, 10.1016/S1072-7515(01)00957-7 Gonzalez-Lira, 1997, Conservative surgery for ovarian cancer and effect on fertility, Int J Gynaecol Obstet, 56, 155, 10.1016/S0020-7292(96)02814-7 Columbo, 1994, Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy, Gynecol Oncol, 55, 451 Zanetta, 1997, Conservative surgery for stage I ovarian carcinoma in women of childbearing age, Br J Obstet Gynaecol, 104, 1030, 10.1111/j.1471-0528.1997.tb12062.x Brown, 2000, Preserving fertility in patients with epithelial ovarian cancer: the role of conservative surgery in treatment of early stage disease, Gynecol Oncol, 76, 40 Morice, 2001, Results of conservative treatment in epithelial ovarian carcinoma, Cancer, 92, 2412, 10.1002/1097-0142(20011101)92:9<2412::AID-CNCR1590>3.0.CO;2-7 1997, Gynecol Oncol, 66, 351, 10.1006/gyno.1997.4849 Fisher, 1995, Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer, N Engl J Med, 333, 1456, 10.1056/NEJM199511303332203 Andrews, 1994, Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva, Gynecol Oncol, 55, 41, 10.1006/gyno.1994.1244 Menczer, 1995, A trend toward more conservative surgery in gynecologic oncology, Obstet Gynecol Surv, 41, 628 Plante, 2000, Fertility preservation in the management of gynecologic cancers, Curr Opin Oncol, 12, 497, 10.1097/00001622-200009000-00018 Piver, 1978, Incidence of subclinical metastasis in stage I and II ovarian carcinoma, Obstet Gynecol, 52, 100 Chen, 1983, Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary, Gynecol Oncol, 15, 95, 10.1016/0090-8258(83)90013-6 Burghardt, 1991, Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer, Gynecol Oncol, 40, 103, 10.1016/0090-8258(91)90099-Q Cass, 2001, Patterns of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas, Gynecol Oncol, 80, 56, 10.1006/gyno.2000.6027 Kottmeier, 1968, Surgical management-conservative surgery Young, 1990, Adjuvant therapy in stage I and stage II epithelial ovarian cancer: results of two prospective randomized trials, N Engl J Med, 322, 1021, 10.1056/NEJM199004123221501 1995, J Am Med Assoc, 8, 491 Le, 1999, Clinically apparent early stage invasive epithelial ovarian carcinoma: Should all be treated similarly?, Gynecol Oncol, 74, 252, 10.1006/gyno.1999.5440 Young, 2000, Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer, Semin Oncol, 27, 8 O'Brien, 1993, Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages, Gynecol Oncol, 49, 250, 10.1006/gyno.1993.1117 Sugiyama, 2000, Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy, Cancer, 88, 2584, 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X Hogberg, 2001, A systematic overview of chemotherapy effects in ovarian cancer, Acta Oncol, 40, 340, 10.1080/02841860151116420 Andrieu, 1983, Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease, Cancer, 52, 435, 10.1002/1097-0142(19830801)52:3<435::AID-CNCR2820520308>3.0.CO;2-1 Gershenson, 1988, Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors, J Clin Oncol, 5, 270, 10.1200/JCO.1988.6.2.270 Kanazawa, 2000, Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission, Am J Clin Oncol, 23, 244, 10.1097/00000421-200006000-00007 Averette, 1990, Effects of cancer chemotherapy on gonadal function and reproductive capacity, Ca J Clin, 40, 199, 10.3322/canjclin.40.4.199 Ahmed, 1996, Natural history and prognosis of untreated stage I epithelial ovarian carcinoma, J Clin Oncol, 14, 2968, 10.1200/JCO.1996.14.11.2968 Young, 1998, Management of early ovarian cancer, Semin Oncol, 25, 335 Pecorelli, 1998, Carcinoma of the ovary. Annual report on the results of treatment of gynaecological cancer, J Epidemiol Biostat, 3, 75 Vergote, 1998, Analysis of prognostic factors in 1287 patients with FIGO stage I invasive ovarian cancer, Proc Am Soc Clin Oncol, 34, 1389